Synthesis, Preclinical Toxicity, and Biodistribution of [ <sup>18</sup> F]AVT-011 to Assess the P-Glycoprotein Function
<b><i>Introduction:</i></b> Many studies have reported the role of P-glycoprotein (Pgp) in chemoresistance in various pathological conditions such as cancer and neurodegenerative diseases, such as Alzheimer's. In this study, we are reporting the high-performance liquid chromatography (HPLC)-based purification of fluorine-18 [<sup>18</sup>F]AVT-011 and its preclinical evaluation. <b><i>Methods:</i></b> AVT-011 was labeled with <sup>18</sup>F using the nucleophilic substitution method by heating the reaction mixture at 110°C for 10 min, followed by purification using preparative HPLC and C18ec cartridge. The <i>in vitro</i> cell uptake study was carried out in U87 cells with and without an inhibitor. The preclinical toxicity was carried out in CD1 mice in three groups, including control, AVT-011 treated, and [<sup>18</sup>F]AVT-011 treated. The biodistribution study was done in CD1 mice (<i>n</i> = 12) after intravenous injection of 4-6 MBq [<sup>18</sup>F]AVT-011, and mice were sacrificed at various time intervals. A dose of 3.7 ± 0.7 MBq of [<sup>18</sup>F]AVT-011 was injected intravenously in the healthy Swiss albino mice, and the whole-body micro-positron emission tomography was acquired at 0-, 30-, 60-, and 120-min postinjection. <b><i>Results:</i></b> The radiochemical purity of [<sup>18</sup>F]AVT-011 was 97 ± 1.5% as evaluated by radio-HPLC with a yield of 14 ± 2% and was stable up to 95% under <i>in vitro</i> conditions in blood and <i>in vivo</i> conditions up to 4 h. The <i>in vitro</i> cell uptake study showed a significant difference in control (27.4 ± 2.1%) and blocked U987 cells (73.2 ± 3.2%) after incubation of 120 min. The tissue distribution in mice showed the highest uptake in the liver (17.3 ± 2.4%), kidneys (16.6 ± 3.1%), lungs (10.4 ± 2.9%), and spleen (5.6 ± 0.8%) at 15 min, and the activity was washed out with time. The radioactivity cleared through the hepatorenal pathway. The animal imaging study also demonstrates a similar biodistribution pattern. <b><i>Conclusions:</i></b> [<sup>18</sup>F]AVT-011 showed higher specific activity than the cartridge-based method but showed similar biological activity.
Authors
- Riptee Thakur
- Bhabani Mohanty (ORCID: https://orcid.org/0000-0003-3387-2545)
- Pardeep Kumar (ORCID: https://orcid.org/0000-0002-1832-798X)
- Manoj Kumar (ORCID: https://orcid.org/0000-0002-2729-7049)
- Aishwarya Kumar (ORCID: https://orcid.org/0000-0002-8271-5127)
- Manjunatha M. Venkataswamy (ORCID: https://orcid.org/0000-0003-3908-7222)
- Afsal Mohammed KM
- Divya Maheshwari
- Hosahalli Mohan
- Pradip Chaudhari
- Raman Kumar Joshi
Institutions
- Medanta The Medicity (IN)
- Cancer Hospital and Research Institute (IN)
- Healthcare Global Enterprises (IN)
- Advanced Centre for Treatment, Research and Education in Cancer (IN)
- National Institute of Mental Health and Neurosciences (IN)
Publication Details
- Journal
- Cancer Biotherapy and Radiopharmaceuticals
- Published
- 2024-09-12
- DOI
- https://doi.org/10.1089/cbr.2024.0114
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00